Clinical Trial Update: Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports completion of a Phase 2 trial evaluating autologous tumor-infiltrating lymphocytes in patients with pretreated metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Autologous tumor infiltrating lymphocytes (TILs)

Snippet

Sponsor: Yale University | Conditions: Metastatic Triple Negative Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-02-23